Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review.

Autor: Wang, H. H., Steffens, E. N., Kats-Ugurlu, G., van Etten, B., Burgerhof, J. G. M., Hospers, G. A. P., Plukker, J. T. M.

Publikováno v: Annals of Surgical Oncology: An Oncology Journal for Surgeons; Jan2024, Vol. 31 Issue 1, p433-451, 19p

Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer

Autor: Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, van Workum, F

Publikováno v: Diseases of the esophagus, 32(12). Wiley-Blackwell
Dis Esophagus
Diseases of the Esophagus, 32(12):doz034. Wiley-Blackwell
Diseases of the Esophagus
Diseases of the Esophagus, 32(12):doz034. Wiley-Blackwell Publishing Ltd
Diseases of the Esophagus, 32
Diseases of the Esophagus, 32, 9
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 32(12). Wiley-Blackwell
Seesing, M F J, Van Der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, Van Den Wildenberg, F J H, Van Berge Henegouwen, M I, Van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P & Van Hillegersberg, R 2020, ' Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer : A nationwide study ', Diseases of the Esophagus, vol. 32, no. 12, doz034 . https://doi.org/10.1093/dote/doz034
Diseases of the esophagus, 32(12):doz034. Wiley-Blackwell

SUMMARY The standard of care for gastroesophageal cancer patients with hepatic or pulmonary metastases is best supportive care or palliative chemotherapy. Occasionally, patients can be selected for curative treatment instead. This study aimed to eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc120a8b2e5541cd8361f05007a6beca
http://www.scopus.com/inward/record.url?scp=85079036588&partnerID=8YFLogxK

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer.

Autor: Wang, H. H., Steffens, E. N., Kats-Ugurlu, G., van Etten, B., Burgerhof, J. G. M., Hospers, G. A. P., Plukker, J. T. M.

Publikováno v: Annals of Surgical Oncology: An Oncology Journal for Surgeons; Jan2024, Vol. 31 Issue 1, p452-453, 2p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.